DIVALSIA ER 250

Divalproex Sodium eq. to Valproic Acid Extended Release 250mg Tablet

 

• A significant reduction in the YMRS and CGI-BP scores from baseline to visit-3, in Indian patients with bipolar I disorder in continuation phase
• Significantly lower risk of psychiatric hospitalization
• Benefits a broader spectrum of bipolar conditions
• Long-term safety and tolerability profile in adults & adolescents with migraine

 

Indications:

• Mania
• Epilepsy
• Bipolar Disorders
• Migraine

 

Query Now!

📞Dial: +91-9316815270, 9499164371, 7988871718
✉️Email: support@curasiamedilabs.com
🌐Visit: www.curasiamedilabs.com

Enquiry